PLP1+ cell-surface staining in the live-cell assay was highly specific for MS CSF samples, with 58.7% of MS and 0% of inflammatory and noninflammatory control patients showing positive staining both visibly and by G/R binding ratios (Figure 9C). This evidence concerns the gene PLP1 and myeloid sarcoma.